Calendar Alkermes plc

Equities

ALKS

IE00B56GVS15

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-17 pm EDT			5-day change	1st Jan Change
29.77 ^USD	+1.19%		-4.40%	+3.51%

Jun. 17	Alkermes' ALKS-2680 Seen as Potential Breakthrough for Narcolepsy, Hypersomnia, BofA Says	MT
Jun. 17	UBS Upgrades Alkermes Public to Buy From Neutral, Adjusts Price Target to $42 From $33	MT

Chart calendar Alkermes plc

1.gOAFI_-EMAzxZHiNnTcJhqHXY5E03q3A5BPE9Xo-Fn0.0NU3abvnXHbJDAr-73Nd1O6ANP1rncKT0COwug8OXg_ah0JRm9xKeLkxDw~b7f5e40d4749d8e5de930781db6cb708

Upcoming events on Alkermes plc

2025-07-22	Q2 2025 Earnings Release (Projected)
2025-10-21	Q3 2025 Earnings Release (Projected)
2026-02-11	Q4 2025 Earnings Release (Projected)
2026-05-05	Q1 2026 Earnings Release (Projected)

Past events on Alkermes plc

2025-06-11 07:15 pm	Associated Professional Sleep Societies Meeting
2025-06-11 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 849
2025-06-11 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 848
2025-06-11 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 838
2025-06-11 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 837
2025-06-11 01:00 pm	Associated Professional Sleep Societies Meeting
2025-06-11 11:30 am	Associated Professional Sleep Societies Meeting - Marcus Yountz
2025-06-10 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 1661
2025-06-09 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 806
2025-06-09 01:00 pm	Associated Professional Sleep Societies Meeting - Abstract ID: 805
2025-06-09 10:00 am	Goldman Sachs Global Healthcare Conference
2025-05-21 08:00 am	Annual General Meeting
2025-05-01 08:00 am	Q1 2025 Earnings Call
2025-05-01 07:00 am	Q1 2025 Earnings Release
2025-04-09 11:45 am	Needham Healthcare Conference
2025-03-12 11:20 am	Leerink Partners Global Healthcare Conference
2025-03-05 09:50 am	TD Cowen Healthcare Conference
2025-02-12 08:00 am	Q4 2024 Earnings Call
2025-02-12 07:00 am	Q4 2024 Earnings Release
2025-01-15 02:15 pm	JP Morgan Healthcare Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	1 112 1 097 1.37%	1 663 1 632 1.9%	1 558 1 506 3.42%	1 386	1 439	1 409
EBITDA Million USD	Released Forecast Spread	-64,4 -23,5 -173.53%	487 383 27.06%	452 441 2.57%	261	269	255
EBIT Million USD	Released Forecast Spread	-142 -138 -3.21%	414 259 59.73%	421 410 2.58%	225	242	201
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-167 -183 8.78%	422 260 62.12%	444 408 8.82%	238	246	197
Net income Million USD	Released Forecast Spread	-158 -166 4.41%	356 265 34.32%	367 329 11.47%	195	203	167
EPS USD	Released Forecast Spread	-0,97 -0,99 2.16%	2,10 1,55 35.33%	2,17 1,94 11.94%	1,16	1,18	0,91
Announcement Date		16/02/23	15/02/24	12/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	381 362 5.12%	377 362 4.17%	350 360 -2.75%	399 393 1.46%	378 381 -0.66%	430 379 13.33%	307 304 0.79%	343	355	381	339	364	368	404
EBITDA Million USD	Released Forecast Spread	78,1 80,8 -3.36%	72,9 106 -31.41%	49,0 114 -56.87%	115 128 -10.54%	112 130 -13.77%	170 137 23.99%	22,8 9,49 139.89%	63,1	80,0	94,8
EBIT Million USD	Released Forecast Spread	43,8 24,0 82.66%	54,6 27,7 96.92%	43,3 90,1 -51.93%	110 120 -8.19%	105 118 -11.51%	163 125 30.38%	13,8 3,39 306.59%	50,7	67,4	89,4	64,6	78,4	76,6	106
Earnings before Tax (EBT) Million USD	Released Forecast Spread	47,4 25,1 88.73%	58,3 11,4 410.15%	46,9 88,9 -47.25%	117 116 0.33%	110 122 -9.84%	170 138 22.7%	25,5 12,5 104.53%	48,9	69,3	95,1	81,7	88,9	86,1	110
Net income Million USD	Released Forecast Spread	47,8 17,3 176.62%	113 22,3 404.8%	36,8 74,9 -50.85%	91,4 96,4 -5.22%	92,4 98,5 -6.19%	147 104 41.47%	22,5 5,27 325.87%	40,4	57,0	75,9	64,6	70,2	68,0	86,9
EPS USD	Released Forecast Spread	0,28 0,10 186.12%	0,66 0,12 470.79%	0,21 0,44 -52.28%	0,53 0,55 -3.04%	0,55 0,57 -2.9%	0,88 0,64 37.74%	0,13 0,05 145.84%	0,25	0,33	0,44	0,39	0,43	0,41	0,53
Announcement Date		25/10/23	15/02/24	01/05/24	24/07/24	24/10/24	12/02/25	01/05/25	-	-	-	-	-	-	-

Upcoming sector events for Alkermes plc

2025-07-22	ALKERMES PLC: Q2 2025 Earnings Release (Projected)
2025-07-22	ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release (Projected)
2025-07-22	SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-22	LONZA GROUP AG: Q2 2025 Earnings Release
2025-07-23 04:01 pm	GALAPAGOS NV: Q2 2025 Earnings Release
2025-07-23	EUROFINS SCIENTIFIC SE: Q2 2025 Earnings Release
2025-07-24 01:00 am	BACHEM HOLDING AG: Q2 2025 Earnings Release
2025-07-24	PHARVARIS N.V.: Q2 2025 Earnings Release (Projected)
2025-07-25 01:00 am	BB BIOTECH AG: Q2 2025 Earnings Release
2025-07-27	MEDPACE HOLDINGS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Alkermes plc

2025-06-10 03:20 am	POLARIS GROUP: May 2025 Sales and Revenue Release
2025-05-29 07:00 am	IMMUNOVANT, INC.: Q4 2025 Earnings Release
2025-05-27	MESOBLAST LIMITED: Q3 2025 Earnings Release (Projected)
2025-05-22 07:00 am	REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release
2025-05-21 02:00 am	BIOARCTIC AB: Q1 2025 Earnings Release
2025-05-20	EXSCIENTIA PLC: Q1 2025 Earnings Release (Projected)
2025-05-20 07:00 am	CUREVAC N.V.: Q1 2025 Earnings Release
2025-05-14	GI INNOVATION, INC.: Q1 2025 Earnings Release
2025-05-14	GNI GROUP LTD.: Q1 2025 Earnings Release
2025-05-14 04:32 pm	SS INNOVATIONS INTERNATIONAL, INC.: Q1 2025 Earnings Release